Digital Early Warning System for Acute Lung Injury in Liver Surgery
Recruiting now · Has a placebo group
Conditions studied: Acute Lung Injury(ALI), Liver Cirrhosis, ARDS, Human, MASLD, MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis), NAFLD (Nonalcoholic Fatty Liver Disease), Liver Cancer, Adult
In brief
This study focuses on developing an explainable machine learning model based on cardiopulmonary interaction characteristics to achieve early prediction of acute lung injury (ALI) in patients undergoing major liver surgery. The research will establish a digital early-warning system for ALI to provide support for clinical diagnosis and treatment decisions, thereby reducing the incidence and fatality rate of ALI.
Key facts
- Study ID
- NCT07070362
- Run by
- Beijing Tsinghua Chang Gung Hospital
- People needed
- 4000
- Starts
- 2024-11-01
- Expected to finish
- 2027-11-30
- Last updated by the study team
- 2025-07-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age ≥ 18 years
- Undergoing major liver surgery (including two-segment or more hepatectomy, liver transplantation, etc.)
- Voluntary participation with signed informed consent
Where it is running
- Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine,Tsinghua University — Beijing, Beijing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.